Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis

BACKGROUND: Higher serum levels of at least one of a panel of four α-glucose IgM antibodies (gMS-Classifier1) in clinically isolated syndrome (CIS) patients are associated with imminent early relapse within 2 years. OBJECTIVE: The objective of this study was to determine the prognostic value of gMS-...

Descripción completa

Detalles Bibliográficos
Autores principales: Freedman, MS, Metzig, C, Kappos, L, Polman, CH, Edan, G, Hartung, H-P, Miller, DH, Montalban, X, Yarden, J, Spector, L, Fire, E, Dotan, N, Schwenke, S, Lanius, V, Sandbrink, R, Pohl, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2012
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546632/
https://www.ncbi.nlm.nih.gov/pubmed/22183938
http://dx.doi.org/10.1177/1352458511432327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546632/
https://www.ncbi.nlm.nih.gov/pubmed/22183938
http://dx.doi.org/10.1177/1352458511432327

Ejemplares similares